Nilotinib in patients with Ph + chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results

P. D. Le Coutre, F. J. Giles, A. Hochhaus, J. F. Apperley, G. J. Ossenkoppele, R. Blakesley, Y. Shou, N. J. Gallagher, M. Baccarani, J. Cortes, H. M. Kantarjian

Research output: Contribution to journal › Article › peer-review

86 Scopus citations

Fingerprint

Dive into the research topics of 'Nilotinib in patients with Ph + chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results'. Together they form a unique fingerprint.

Medicine & Life Sciences